Cromos Pharma, where the patients are

Global News

The Pulse on Study Conduct By Elizabeth Weeks-Rowe

Monday, April 21, 2014 07:01 AM

Everyone has the occasional poor performance in clinical research. Study coordinators may fail to report a serious adverse event. Monitors may overlook an incorrect version of an informed consent form. Without the occasional failure, we would not progress—in learning, adapting or growing as clinical researchers. Error is the most effective learning tool, with the dual outcomes of compliance and retention.

More... »

CRF Health eCOA webinar series

Cancer Research U.K. to launch 14-drug, personalized medicine trial

Friday, April 18, 2014 01:57 PM

British researchers, working with two global pharmaceutical companies, are planning to launch a different kind of personalized medicine clinical trial that could change how cancer drugs are studied and potentially cut the time and cost of bringing them to market.

More... »


Report: Biomarker market for diagnostic applications to reach $30.6B globally by 2020

Friday, April 18, 2014 12:40 PM

According to a new report from Allied Market Research, the global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020.

More... »

AMRI shutters New York research center, cuts 45 jobs

Friday, April 18, 2014 12:39 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y., site to other sites within AMRI and will cease operations in Syracuse by the end of June.

More... »

SMART Platforms Project names advisory committee

Friday, April 18, 2014 11:26 AM

The SMART (Substitutable Medical Apps & Reusable Technology) Platforms project at Boston Children's Hospital—which is developing technology to create an app-driven health information economy—has announced the formation of an advisory committee that will guide the project on strategy, technical approach and business development.

More... »

First patient enrolled in Boston Scientific’s new clinical registry

Friday, April 18, 2014 10:43 AM

Boston Scientific has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise Deep Brain Stimulation (DBS) System in patients with Parkinson's disease (PD).

More... »

Ian Read becomes PhRMA board chairman; Ken Frazier, George Scangos on board

Friday, April 18, 2014 10:37 AM

Ian C. Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA). Read succeeds Robert J. Hugin, chairman and CEO of Celgene, as PhRMA's chairman. Also elected were Kenneth C. Frazier, chairman, president and CEO of Merck, as chairman-elect of the PhRMA board of directors, and George A. Scangos, Ph.D., CEO of Biogen Idec, as board treasurer.

More... »

Report: Healthcare M&As led by IT deals

Thursday, April 17, 2014 02:31 PM

The outlook for mergers and acquisitions in the healthcare/pharmaceutical information technology industry remains strong despite fewer transactions in 2013. But a broader mix of acquirers is looking to purchase companies that can improve clinical outcomes while reducing expenditures, according to a white paper from investment banker BerkeryNoyes.

More... »

ePharmaSolutions' ReferralPlus increases match rate for trial volunteers

Thursday, April 17, 2014 11:22 AM

ePharmaSolutions, a provider of eClinical solutions, says results of initial pilot studies for its patient matching and triaging solution, ReferralPlus, show a significant improvement in match rates for people actively searching for clinical trials in which to participate.

More... »

Drug developers use new models and methods to boost clinical success rates

Thursday, April 17, 2014 11:21 AM

Drug companies and their development partners seeking to increase clinical trial success rates of new drug candidates are developing tools to help them predict the likelihood of marketing approval and incorporating business planning earlier in clinical development, according to R&D leaders who recently participated in a roundtable discussion convened by the Tufts Center for the Study of Drug Development (CSDD).

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs